SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    G. Amaddeo, Q. Cao, Y. Ladeiro, S. Imbeaud, J.-C. Nault, D. Jaoui, Y. Gaston Mathe, C. Laurent, A. Laurent, P. Bioulac-Sage, J. Calderaro, J. Zucman-Rossi, Integration of tumour and viral genomic characterisations in HBV-related hepatocellular carcinomas, Gut, 2015, 64, 5, 820

    CrossRef

  2. 2
    Lu-Nan Qi, Tao Bai, Zu-Shun Chen, Fei-Xiang Wu, Yuan-Yuan Chen, Bang- De Xiang, Tao Peng, Ze-Guang Han, Le-Qun Li, The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure, Liver International, 2015, 35, 3
  3. 3
    F. Raad, L. Nasreddine, C. Hilan, M. Bartosik, D. Parent-Massin, Dietary exposure to aflatoxins, ochratoxin A and deoxynivalenol from a total diet study in an adult urban Lebanese population, Food and Chemical Toxicology, 2014, 73, 35

    CrossRef

  4. 4
    Sung-Min Ahn, Se Jin Jang, Ju Hyun Shim, Deokhoon Kim, Seung-Mo Hong, Chang Ohk Sung, Daehyun Baek, Farhan Haq, Adnan Ahmad Ansari, Sun Young Lee, Sung-Min Chun, Seongmin Choi, Hyun-Jeung Choi, Jongkyu Kim, Sukjun Kim, Shin Hwang, Young-Joo Lee, Jong-eun Lee, Wang-rim Jung, Hye Yoon Jang, Eunho Yang, Wing-Kin Sung, Nikki P. Lee, Mao Mao, Charles Lee, Jessica Zucman-Rossi, Eunsil Yu, Han Chu Lee, Gu Kong, Genomic portrait of resectable hepatocellular carcinomas: Implications of RB1 and FGF19 aberrations for patient stratification, Hepatology, 2014, 60, 6
  5. 5
    Sreetha Sidharthan, Shyam Kottilil, Mechanisms of alcohol-induced hepatocellular carcinoma, Hepatology International, 2014, 8, S2, 452

    CrossRef

  6. 6
    Raffi Karagozian, Zoltán Derdák, György Baffy, Obesity-associated mechanisms of hepatocarcinogenesis, Metabolism, 2014, 63, 5, 607

    CrossRef

  7. 7
    Jeng-Wei Lu, Wan-Yu Yang, Yueh-Min Lin, Shiow-Lian Catherine Jin, Chiou-Hwa Yuh, Hepatitis B virus X antigen and aflatoxin B1 synergistically cause hepatitis, steatosis and liver hyperplasia in transgenic zebrafish, Acta Histochemica, 2013, 115, 7, 728

    CrossRef

  8. 8
    Yongdong Niu, Zheng Wu, Qiujin Shen, Jin Song, Qin Luo, Haiyan You, Ganggang Shi, Wenxin Qin, Hepatitis B virus X protein co-activates pregnane X receptor to induce the cytochrome P450 3A4 enzyme, a potential implication in hepatocarcinogenesis, Digestive and Liver Disease, 2013, 45, 12, 1041

    CrossRef

  9. 9
    Brian I. Carr, Vito Guerra, Thrombocytosis and Hepatocellular Carcinoma, Digestive Diseases and Sciences, 2013, 58, 6, 1790

    CrossRef

  10. 10
    Johanna C. Bruneau, Edwina Stack, Richard O’Kennedy, Christine E. Loscher, Aflatoxins B1, B2 and G1 modulate cytokine secretion and cell surface marker expression in J774A.1 murine macrophages, Toxicology in Vitro, 2012, 26, 5, 686

    CrossRef

  11. 11
    Arinze S. Okoli, Mark J. Raftery, George L. Mendz, Comparison ofHelicobacter bilis-Associated Protein Expression in Huh7 Cells Harbouring HCV Replicon and in Replicon-Cured Cells, International Journal of Hepatology, 2012, 2012, 1

    CrossRef

  12. 12
    M. Lereau, D. Gouas, S. Villar, A. Besaratinia, A. Hautefeuille, P. Berthillon, G. Martel-Planche, A. Nogueira da Costa, S. Ortiz-Cuaran, O. Hantz, G. P. Pfeifer, P. Hainaut, I. Chemin, Interactions between hepatitis B virus and aflatoxin B1: effects on p53 induction in HepaRG cells, Journal of General Virology, 2012, 93, 3, 640

    CrossRef

  13. You have free access to this content13
    D. Alan Herbst, K. Rajender Reddy, Risk factors for hepatocellular carcinoma, Clinical Liver Disease, 2012, 1, 6
  14. 14
    Betsy Foxman, Molecular Tools and Infectious Disease Epidemiology, 2012,

    CrossRef

  15. 15
    James H. Lewis, David E. Kleiner, MacSween's Pathology of the Liver, 2012,

    CrossRef

  16. 16
    Nsikak J. Umoh, Olufunmilayo A. Lesi, Maimuna Mendy, Ebrima Bah, Aliu Akano, Hilton Whittle, Pierre Hainaut, Gregory D. Kirk, Aetiological differences in demographical, clinical and pathological characteristics of hepatocellular carcinoma in The Gambia, Liver International, 2011, 31, 2
  17. 17
    Chang-Hai Li, Yan-Jun Wang, Wei Dong, Shuai Xiang, Hui-Fang Liang, Heng-Yi Wang, Han-Hua Dong, Lin Chen, Xiao-Ping Chen, Hepatic oval cell lines generate hepatocellular carcinoma following transfection with HBx gene and treatment with aflatoxin B1 in vivo, Cancer Letters, 2011, 311, 1, 1

    CrossRef

  18. 18
    T. Pollicino, C. Saitta, G. Raimondo, Hepatocellular carcinoma: the point of view of the hepatitis B virus, Carcinogenesis, 2011, 32, 8, 1122

    CrossRef

  19. 19
    Meng Li, Hong Zhao, Xiaosong Zhang, Laura D Wood, Robert A Anders, Michael A Choti, Timothy M Pawlik, Hubert D Daniel, Rajesh Kannangai, G Johan A Offerhaus, Victor E Velculescu, Linfang Wang, Shibin Zhou, Bert Vogelstein, Ralph H Hruban, Nick Papadopoulos, Jianqiang Cai, Michael S Torbenson, Kenneth W Kinzler, Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma, Nature Genetics, 2011, 43, 9, 828

    CrossRef

  20. 20
    Stéphanie Villar, Emilie Le Roux-Goglin, Doriane A. Gouas, Amelie Plymoth, Gilles Ferro, Mathieu Boniol, Myriam Lereau, Ebrima Bah, Andrew J. Hall, Christopher P. Wild, Maimuna Mendy, Helene Norder, Marianne van der Sande, Hilton Whittle, Marlin D. Friesen, John D. Groopman, Pierre Hainaut, Seasonal Variation in TP53 R249S-Mutated Serum DNA with Aflatoxin Exposure and Hepatitis B Virus Infection, Environmental Health Perspectives, 2011, 119, 11, 1635

    CrossRef

  21. 21
    D. A. Gouas, H. Shi, A. H. Hautefeuille, S. L. Ortiz-Cuaran, P. C. Legros, K. J. Szymanska, O. Galy, L. A. Egevad, B. Abedi-Ardekani, K. G. Wiman, O. Hantz, C. Caron de Fromentel, I. A. Chemin, P. L. Hainaut, Effects of the TP53 p.R249S mutant on proliferation and clonogenic properties in human hepatocellular carcinoma cell lines: interaction with hepatitis B virus X protein, Carcinogenesis, 2010, 31, 8, 1475

    CrossRef

  22. 22
    M.C. Kew, Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma, Pathologie Biologie, 2010, 58, 4, 273

    CrossRef

  23. 23
    James H. Lewis, Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 2010,

    CrossRef

  24. 24
    Christopher P. Wild, Ruggero Montesano, A model of interaction: Aflatoxins and hepatitis viruses in liver cancer aetiology and prevention, Cancer Letters, 2009, 286, 1, 22

    CrossRef

  25. 25
    J.-C. Trinchet, Carcinome hépatocellulaire : une incidence croissante, une prise en charge « optimisée », Gastroentérologie Clinique et Biologique, 2009, 33, 8-9, 830

    CrossRef

  26. 26
    Michael C. Kew, Hepatic iron overload and hepatocellular carcinoma, Cancer Letters, 2009, 286, 1, 38

    CrossRef

  27. 27
    Quoc V Tu, Arinze S Okoli, Zsuzsanna Kovach, George L Mendz, Hepatocellular carcinoma: prevalence and molecular pathogenesis ofHelicobacterspp., Future Microbiology, 2009, 4, 10, 1283

    CrossRef

  28. 28
    David E. Williams, Gayle Orner, Kristin D. Willard, Susan Tilton, Jerry D. Hendricks, Clifford Pereira, Abby D. Benninghoff, George S. Bailey, Rainbow trout (Oncorhynchus mykiss) and ultra-low dose cancer studies, Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, 2009, 149, 2, 175

    CrossRef

  29. 29
    Doriane Gouas, Hong Shi, Pierre Hainaut, The aflatoxin-induced TP53 mutation at codon 249 (R249S): Biomarker of exposure, early detection and target for therapy, Cancer Letters, 2009, 286, 1, 29

    CrossRef

  30. 30
    Mark H. Kuniholm, Olufunmilayo A. Lesi, Maimuna Mendy, Aliu O. Akano, Omar Sam, Andrew J. Hall, Hilton Whittle, Ebrima Bah, James J. Goedert, Pierre Hainaut, Gregory D. Kirk, Aflatoxin Exposure and Viral Hepatitis in the Etiology of Liver Cirrhosis in The Gambia, West Africa, Environmental Health Perspectives, 2008, 116, 11, 1553

    CrossRef

  31. 31
    J. Ferrís i Tortajada, J.A. Ortega García, J. Garcia i Castell, J.A. López Andreu, C. Ribes Koninckx, O. Berbel Tornero, Factores de riesgo para los tumores hepáticos malignos pediátricos, Anales de Pediatría, 2008, 68, 4, 377

    CrossRef

  32. 32
    Zhi-Ming Liu, Le-Qun Li, Min-Hao Peng, Tang-Wei Liu, Zhong Qin, Ya Guo, Kai-Yin Xiao, Xin-Ping Ye, Xin-Shao Mo, Xue Qin, Shan Li, Lu-Nan Yan, Han-Ming Shen, LianWen Wang, Qiao Wang, Kai-bo Wang, Ren-xiang Liang, Zong-liang Wei, Choon Nam Ong, Regina M. Santella, Tao Peng, Hepatitis B virus infection contributes to oxidative stress in a population exposed to aflatoxin B1 and high-risk for hepatocellular carcinoma, Cancer Letters, 2008, 263, 2, 212

    CrossRef

  33. 33
    H. Shi, J. M.R. Lambert, A. Hautefeuille, V. J.N. Bykov, K. G. Wiman, P. Hainaut, C. C. de Fromentel, In vitro and in vivo cytotoxic effects of PRIMA-1 on hepatocellular carcinoma cells expressing mutant p53ser249, Carcinogenesis, 2008, 29, 7, 1428

    CrossRef

  34. 34
    Michael Fasullo, Mingzeng Sun, Patricia Egner, Stimulation of sister chromatid exchanges and mutation by aflatoxin B1-DNA adducts in Saccharomyces cerevisiae requires MEC1 (ATR), RAD53, and DUN1, Molecular Carcinogenesis, 2008, 47, 8
  35. 35
    Erika L. Abel, John DiGiovanni, The Molecular Basis of Cancer, 2008,

    CrossRef

  36. 36
    Ken Sexton, Dale Hattis, Assessing Cumulative Health Risks from Exposure to Environmental Mixtures—Three Fundamental Questions, Environmental Health Perspectives, 2007, 115, 5, 825

    CrossRef

  37. 37
    George A. Asare, Michelle Bronz, Vivash Naidoo, Michael C. Kew, Interactions between aflatoxin B1 and dietary iron overload in hepatic mutagenesis, Toxicology, 2007, 234, 3, 157

    CrossRef

  38. 38
    S P Hussain, J Schwank, F Staib, X W Wang, C C Harris, TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer, Oncogene, 2007, 26, 15, 2166

    CrossRef

  39. 39
    Avishay-Abraham Stark, Microbial Food Contamination, Second Edition, 2007,

    CrossRef

  40. 40
    A. ZIMMERMANN, Surgery of the Liver, Biliary Tract and Pancreas, 2007,

    CrossRef

  41. 41
    C.R. KELLY, J.R. WANDS, Surgery of the Liver, Biliary Tract and Pancreas, 2007,

    CrossRef

  42. 42
    B. Dash, E. Afriyie-Gyawu, H. J. Huebner, W. Porter, J. S. Wang, P. E. Jolly, T. D. Phillips, Determinants of the Variability of Aflatoxin–Albumin Adduct Levels in Ghanaians, Journal of Toxicology and Environmental Health, Part A, 2006, 70, 1, 58

    CrossRef

  43. 43
    Paraskevi A. Farazi, Ronald A. DePinho, Hepatocellular carcinoma pathogenesis: from genes to environment, Nature Reviews Cancer, 2006, 6, 9, 674

    CrossRef

  44. 44
    D. Candotti, O. Opare-Sem, H. Rezvan, F. Sarkodie, J.-P. Allain, Molecular and serological characterization of hepatitis B virus in deferred Ghanaian blood donors with and without elevated alanine aminotransferase, Journal of Viral Hepatitis, 2006, 13, 11
  45. 45
    Flor H Pujol, Marisol Devesa, Genotypic Variability of Hepatitis Viruses Associated With Chronic Infection and the Development of Hepatocellular Carcinoma, Journal of Clinical Gastroenterology, 2005, 39, 7, 611

    CrossRef

  46. 46
    Beate Friedrich, Madlen Wollersheim, Boerries Brandenburg, Ramona Foerste, Hans Will, Eberhard Hildt, Induction of anti-proliferative mechanisms in hepatitis B virus producing cells, Journal of Hepatology, 2005, 43, 4, 696

    CrossRef

  47. 47
    A.C. Paterson, K. Cooper, Tumours and tumour-like lesions of the hepatic parenchyma, Current Diagnostic Pathology, 2005, 11, 1, 19

    CrossRef

  48. 48
    Karen Man-Fong Sze, Yick-Pang Ching, Dong-Yan Jin, Irene Oi-Lin Ng, Association of MAD2 expression with mitotic checkpoint competence in hepatoma cells, Journal of Biomedical Science, 2004, 11, 6, 920

    CrossRef

  49. You have free access to this content49
    Aflatoxine [MAK Value Documentation in German language, 2008], The MAK Collection for Occupational Health and Safety,